Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia – EurekAlert (press release)
EurekAlert (press release) |
Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia
EurekAlert (press release) The findings, published online in the journal Blood, provide the basis for launching a first-in-human clinical trial of this new immunotherapy, which relies on engineered T-cell receptors, or TCRs. This immunotherapy represents a different method of … |
